Trial intelligence / Profile preview

Hypertonic Lactate vs Ringer's Lactate in Post-CABG Patients

NCT00529490Phase 3Completed

Sponsor
Innogene Kalbiotech
Start
Mar 2002
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of hypertonic sodium lactate in Low cardiac output syndrome (LCOS), sponsored by Innogene Kalbiotech. Started Mar 2002; status: completed.

02

Drugs

hypertonic sodium lactate
03

Conditions

Low cardiac output syndrome (LCOS)

Beyond the preview

Go deeper on NCT00529490.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00529490.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call